Abstract:MicroRNAs (miRNAs) were previously demonstrated to be involved in the pathogenesis of non‐small‐cell lung cancer (NSCLC); however, the roles of certain miRNAs in NSCLC remain to be elucidated. The present study aimed to investigate the functions of screened miRNAs in NSCLC and the potential mechanisms. First, expression profiles of miRNAs were downloaded from the Gene Expression Omnibus (dataset no. GSE29248) and the differentially expressed miRNAs were analyzed by bioinformatics methods. Reverse transcription‐quantitative PCR was used to validate the differential expression of miR‐373 in clinical samples. The association between miR‐373 expression levels and clinicopathological characteristics was also investigated. To further examine how miR‐373 mediates the emergence of NSCLC, western blot, Cell Counting Kit‐8, cell invasion and wound‐healing assays, as well as apoptosis detection and a luciferase assay were used. The results indicated significant downregulation of miR‐373 in NSCLC tissues and its low expression was closely associated with the degree of differentiation, clinical stage and tumor size, and was indicative of an unfavorable prognosis for patients with NSCLC. A functional study indicated that overexpression of miR‐373 inhibited the proliferation, promoted apoptosis, and suppressed invasion and migration of NSCLC cells. Bioinformatics prediction and functional assays suggested that Grb‐associated binding protein 2 (GAB2) was a direct target of miR‐373. In addition, GAB2 was found to be significantly upregulated in NSCLC tissues, and clinically, miR‐373 was negatively associated with GAB2. Furthermore, overexpression of GAB2 blocked the tumor suppressive effects of miR‐373 on NSCLC cells. Mechanistically, miR‐373 mimics were able to reduce the expression of GAB2 and subsequently decrease the phosphorylation level of AKT and mTOR protein. The present results indicate that miR‐373 exerts its anti‐tumor effects in NSCLC cells by targeting the GAB2/PI3K/AKT pathway, suggesting that miR‐373 may be a potential therapeutic target in NSCLC.

MicroRNA-221-3p promotes proliferation and invasion in non-small cell lung cancer via targeting Axin2 to regulate Wnt/β-catenin signaling pathway

MiRNA-20a-5p accelerates the proliferation and invasion of non-small cell lung cancer by targeting and downregulating KLF9.

Mir‑140‑5p Regulates Cell Migration and Invasion of Non‑small Cell Lung Cancer Cells Through Targeting VEGFA.

Upregulation of Long Intergenic Non-Coding RNA LINC00326 Inhibits Non-Small Cell Lung Carcinoma Progression by Blocking Wnt/β-catenin Pathway Through Modulating the Mir-657/Dickkopf WNT Signaling Pathway Inhibitor 2 Axis

MicroRNA-1253 Suppresses Cell Proliferation and Invasion of Non-Small-cell Lung Carcinoma by Targeting WNT5A

MicroRNA‐147b Suppresses the Proliferation and Invasion of Non‐small‐cell Lung Cancer Cells Through Downregulation of Wnt/β‐catenin Signalling Via Targeting of RPS15A

miR-489-3p promotes malignant progression of non-small cell lung cancer through the inactivation of Wnt/β-catenin signaling pathway via regulating USP48

Mir‑20b Promotes Growth of Non‑small Cell Lung Cancer Through a Positive Feedback Loop of the Wnt/β‑catenin Signaling Pathway

miR-3120-5p promotes colon cancer stem cell stemness and invasiveness through targeting Axin2

MicroRNA‐373‐3p inhibits the proliferation and invasion of non‐small‐cell lung cancer cells by targeting the GAB2/PI3K/AKT pathway

Downregulation of LINC00665 Confers Decreased Cell Proliferation and Invasion Via the Mir-138-5p/e2f3 Signaling Pathway in NSCLC.

Microrna-15b Promotes Proliferation and Invasion of Non-Small Cell Lung Carcinoma Cells by Directly Targeting Timp2

Long Non-Coding RNA ZNF674-AS1 Regulates Mir-23A/e-cadherin Axis to Suppress the Migration and Invasion of Non-Small Cell Lung Cancer Cells

MicroRNA-17-5p Inhibits Proliferation and Triggers Apoptosis in Non-Small Cell Lung Cancer by Targeting Transforming Growth Factor Β Receptor 2.

MicroRNA‑433 Reduces Cell Proliferation and Invasion in Non‑small Cell Lung Cancer Via Directly Targeting E2F Transcription Factor 3.

miR-6884-5p inhibits proliferation and epithelial-mesenchymal transition in non-small cell lung cancer cells

Aberrantly Expressed Mir-582-3p Maintains Lung Cancer Stem Cell-Like Traits by Activating Wnt/β-catenin Signalling

SNX-2112 Induces Apoptosis and Inhibits Proliferation, Invasion, and Migration of Non-Small Cell Lung Cancer by Downregulating Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Signaling Pathway

Long non-coding RNA Xist promotes progression of non-small-cell lung cancer ( NSCLC ) by modulating miR-103 a and MAP 3 K 3 pathway

MicroRNA-30d-5p Inhibits Tumour Cell Proliferation and Motility by Directly Targeting CCNE2 in Non-Small Cell Lung Cancer.

MicroRNA-33b Inhibits Lung Adenocarcinoma Cell Growth, Invasion, and Epithelial-Mesenchymal Transition by Suppressing Wnt/β-catenin/ZEB1 Signaling